IDERA PHARMACEUTICALS INC's ticker is and the CUSIP is 45168K906. A total of 3 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $93,000 | -88.9% | 416 | -84.6% | 0.01% | -87.0% |
| Q4 2015 | $836,000 | -2.5% | 2,707 | +5.8% | 0.05% | +31.4% |
| Q3 2015 | $857,000 | +20.0% | 2,558 | +33.0% | 0.04% | +34.6% |
| Q2 2015 | $714,000 | -55.7% | 1,924 | -47.3% | 0.03% | -49.0% |
| Q4 2014 | $1,611,000 | +99.4% | 3,652 | +3.5% | 0.05% | +64.5% |
| Q3 2014 | $808,000 | +417.9% | 3,529 | +555.9% | 0.03% | +342.9% |
| Q2 2014 | $156,000 | -3.7% | 538 | +35.2% | 0.01% | -22.2% |
| Q1 2014 | $162,000 | – | 398 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 3,529 | $808,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 85,300 | $195,000 | 0.00% |
| Citadel Advisors | 24,100 | $55,000 | 0.00% |